Mrs Laura Wylie, MSOTR/L | |
214 Beagle Gap Run, Waynesboro, VA 22980-9321 | |
(434) 284-3011 | |
Not Available |
Full Name | Mrs Laura Wylie |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 214 Beagle Gap Run, Waynesboro, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093158545 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 0119005938 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Laura Wylie, MSOTR/L 214 Beagle Gap Run, Waynesboro, VA 22980-9321 Ph: (434) 284-3011 | Mrs Laura Wylie, MSOTR/L 214 Beagle Gap Run, Waynesboro, VA 22980-9321 Ph: (434) 284-3011 |
News Archive
Researchers at Duke University Medical Center have provided the first direct evidence in mice for the role of an enzyme that specifically controls the production of serotonin in the brain.
The U.S. Food and Drug Administration today announced that an orthopedic device used in the knee should not have been cleared for marketing in the United States. The announcement follows a re-evaluation of the scientific evidence that was undertaken after a September 2009 agency report identified problems in the agency's review of the device.
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
Bacteria provide a well-known playground for scientists and the evolution of these earliest life forms has shed important perspective on potential therapies for some of the most common, deadly diseases. Researchers at Case Western Reserve University School of Medicine have now discovered that, the gas nitric oxide (NO), produced in all cells of the human body for natural purposes, plays a fundamental regulatory role in controlling bacterial function, via a signaling mechanism called S-nitrosylation (SNO), which binds NO to protein molecules.
Writing in RH Reality Check, Heather Sayette of Planned Parenthood Global/Latin America examines how Ecuador's newly re-elected President Rafael Correa this week "voiced unconditional support for contraception, including emergency contraception."
› Verified 5 days ago
Eric Utz, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 Oak Ave, Waynesboro, VA 22980 Phone: 540-941-3100 | |
Pamela J Vandevander, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 Oak Ave, Waynesboro, VA 22980 Phone: 540-941-3100 | |
Leah L Showalter, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 Oak Ave, Waynesboro, VA 22980 Phone: 540-941-3100 | |
Beth Wampler Gimbert, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 301 Pine Ave, Waynesboro, VA 22980 Phone: 540-946-4600 | |
Mrs. Melinda Bosserman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 64 Amelia Dr, Waynesboro, VA 22980 Phone: 540-447-4030 | |
Dr. Chelsea Maureen Landry, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 W 12th St Ste A1-100, Waynesboro, VA 22980 Phone: 540-941-5501 |